Hemorrhoidectomy With or Without Lateral Internal Sphincterotomy in Management of Patients With Hemorrhoids
NCT ID: NCT06884774
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2024-12-20
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemorrhoidectomy Only Versus Hemorrhoidectomy With Lateral Internal Sphincterotomy
NCT06588374
Anoplasty for Post Hemorroidectomy Anal Stenosis : Diamond Versus V-Y Flap Techniques
NCT05389475
Trans-perineal Repair With or Without Limited Internal Sphincterotomy for Treatment of Type I Anterior Rectocele
NCT02659176
Mucopexy Versus Laser Hemorrhoidoplasty for the Treatment of Hemorrhoidal Disease
NCT04881344
Minimal Invasive Laser Hemorrhoidoplasty vs Conventional Excisional Hemorrhoidectomy in II-III Grade Hemorrhoidal Disease
NCT04944407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, there are many drawbacks to such techniques, such as postoperative pain and constipation. The cause of this postoperative pain is multifactorial. Spasm of the internal anal sphincter (IAS) is one of the factors which is exposed and impinged after EH. Therefore, Lateral internal sphincterotomy (LIS) is a widely used adjunct treatment after EH, which can abolish spasms of the IAS and subsequently relieve postoperative pain.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lateral internal sphincterotomy group
Patients undergoing Hemorrhoidectomy with lateral internal sphincterotomy.
Hemorrhoidectomy with lateral internal sphincterotomy
Patients undergoing Hemorrhoidectomy with lateral internal sphincterotomy.
Control group
Patients undergoing Hemorrhoidectomy without lateral internal sphincterotomy.
Hemorrhoidectomy
Patients undergoing Hemorrhoidectomy without lateral internal sphincterotomy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemorrhoidectomy with lateral internal sphincterotomy
Patients undergoing Hemorrhoidectomy with lateral internal sphincterotomy.
Hemorrhoidectomy
Patients undergoing Hemorrhoidectomy without lateral internal sphincterotomy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sexes.
* All patients indicated for surgical Hemorrhoidectomy (2nd, 3rd, and 4th degree piles).
Exclusion Criteria
* Patients with piles plus fissure.
* Age above 70 years old
* Unfit for surgery.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdelrahman Mohamed Salah
Lecturer of General Surgery, Faculty of Medicine, Minia University, Minia, Egypt.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minia University
Minya, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1230/08/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.